PROVIDER PROFILE · NPI 1245421429

Ammar AhmedMD

DermatologyAustin, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

528

Unique beneficiaries

—

Total services

1,020

Distinct HCPCS

Medicare payment

$35K

Peer benchmark

Total Medicare services vs. 965 Dermatology providers in TX — bottom quintile (cohort median 2,537).

PRESCRIBING · PART D · 2024

Total Rx claims

311

Beneficiaries

—

Total drug cost

$172K

Distinct drugs

Brand share

14.1%

Top prescribed drugs

Clobetasol Propionate77 claims

Triamcinolone Acetonide66 claims

Ketoconazole38 claims

Dupilumab26 claims

Fluorouracil23 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$398

Payment records

By payment type

Food and Beverage$398

Top paying entities

Food and Beverage$398

REFERRAL NETWORK

Where Ammar Ahmed's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 5 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Clinical Pathology Laboratories, Inc. Clinical Laboratory · Austin, TX	103	205
Elizabeth Goman Internal Medicine · Bradenton, FL	19	31

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Clinical Pathology Laboratories, Inc. Clinical Laboratory · Austin, TX	49	76
ASCENSION SETON	16	24
CENTRAL TEXAS COMMUNITY HEALTH CENTERS	16	29
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Irving, TX	13	16
Matthew Fox Dermatology · Austin, TX	11	13

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history